MedPath

Subcutaneous Adipose Tissue in Cases With Polycystic Ovarian Syndrome

Completed
Conditions
Polycystic Ovary Syndrome
Registration Number
NCT01310569
Lead Sponsor
Gulhane School of Medicine
Brief Summary

This study aimed to search whether whole body and subcutaneous adipose tissues increase in PCOS patients and whether these tissues are related to HOMA-IR and plasma adiponectin levels.

Detailed Description

Fifty-two patients with PCOS and fifty-tree healthy controls who were matched for body mass index (BMI) and age (p=0.430, p=0.112, respectively) were enrolled in the study. Biceps, triceps, subscapular and suprailiac skinfold thicknesses (SFT) of all cases were measured via caliper device; mid-upper arm circumference (MUAC) via a tape; and body fat distributions via a bioelectrical impedance device. Insulin resistance was calculated via HOMA-IR while ELISA was used to measure plasma adiponectin.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
52
Inclusion Criteria
  • All of the women with PCOS had normal thyroid-stimulating hormone and prolactin (PRL) levels.
Exclusion Criteria
  • Subjects with possible ovarian tumors, congenital adrenal hyperplasia, BMI greater than 35 kg/m2, any chronic renal or liver disease, were excluded from the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relationship of Subcutaneous Adipose Tissue with HOMA-IR and Plasma Adiponectin Levels in Cases with Polycystic Ovarian Syndrome2 year

PCOS patients (the experimental group) had higher mean SFT values in all parts, mid-upper arm circumference values, whole body and trunk fat free mass amounts (FFM) and HOMA-IR values, while a lower adiponectin level.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Gulhane School of Medicine Department of Endocrinology and Metabolism

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath